FDA Authorizes AI Platform for Breast Cancer Prediction
The FDA grants De Novo authorization for a new device for future five-year breast cancer risk prediction, based on an image alone.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
